Back to Results
First PageMeta Content
Non-nucleoside reverse transcriptase inhibitors / Pyrimidines / Etravirine / Organobromides / Darunavir / Rilpivirine / Least developed country / European Medicines Agency / Organic chemistry / Chemistry / Nitriles


Global HIV Access & Partnerships Program GAPP Status: Branded Registration Efforts AT JANSSEN, a comprehensive, multi-country registration effort ensures timely availability of our branded HIV medicines where there is a
Add to Reading List

Document Date: 2012-07-18 12:13:42

Open Document

File Size: 148,53 KB

Share Result on Facebook

City

Salvador / /

Company

Janssen Global Services LLC / /

Continent

Europe / /

Country

Thailand / Indonesia / South Africa / United States / India / Vietnam / /

Event

FDA Phase / /

IndustryTerm

HIV treatment / /

MedicalCondition

HIV / /

Organization

FDA / Stringent Regulatory Authority / World Health Organization / European Medicines Agency / U.S Food and Drug Administration / /

Product

INTELENCE / PREZISTA / HIV / EDURANT® (rilpivirine) / LMICs3 / /

Region

Sub-Saharan Africa / South Africa / /

URL

www.janssenrnd.com / /

SocialTag